Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104974149B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104974149B enables cost-effective Rivaroxaban synthesis without palladium. Reliable supply chain for high-purity anticoagulant intermediates.